Skip to main content
. 2021 Apr 29;12:664181. doi: 10.3389/fphar.2021.664181

FIGURE 4.

FIGURE 4

EMPA ameliorated SNT-triggered cardiomyocyte death and cell viability loss. (A) Representative images of TUNEL positive cells in mice hearts at the study endpoint among different groups and (C) statistical analysis, n = 6 per group, bar = 50 μm. (B) Representative images of Hoechst 33,258 staining in H9c2 cells with different treatments and (D) statistical analysis, n = 6 per group, bar = 50 μm. (E) CCK-8 viability assay of H9c2 cardiomyocytes treated with vehicle or different concentrations of SNT (ranging from 1 to 20 μM), n = 6 per group. (F) CCK-8 viability assay of H9c2 cardiomyocytes treated by vehicle, SNT (5 μM), or SNT plus EMPA (ranging from 50 to 1,000 nM), n = 6 per group. *p < 0.05 vs. control, #p < 0.05 vs. SNT.